批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/10/10 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/07/08 |
SUPPL-53(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2024/06/20 |
SUPPL-52(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/03/22 |
SUPPL-50(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/03/22 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/14 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/08/14 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/09/05 |
SUPPL-42(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/12/24 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2014/07/21 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/09/28 |
SUPPL-35(补充) |
Approval |
Labeling |
|
|
|
2007/10/25 |
SUPPL-29(补充) |
Approval |
Labeling |
|
|
|
2001/06/27 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2001/05/29 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2000/07/07 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1997/05/21 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
1994/05/11 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1993/06/22 |
SUPPL-14(补充) |
Approval |
Labeling |
|
|
|
1992/09/01 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1990/10/12 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/10/24 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1986/04/22 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/05/21 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/05/21 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/05/21 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/05/21 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/05/21 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1984/12/06 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:METRONIDAZOLE 剂型/给药途径:TABLET;ORAL 规格:250MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
070027 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1984/11/06
|
TEVA PHARMS USA |
070035 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1984/12/20
|
WATSON LABS |
070040 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1985/01/29
|
STRIDES PHARMA |
070772 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
1986/07/16
|
INNOGENIX |
079067 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2009/03/13
|
ALEMBIC PHARMS LTD |
203458 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2014/01/22
|
UNICHEM |
203974 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2015/05/29
|
AUROBINDO PHARMA LTD |
205245 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2015/09/23
|
APPCO |
207309 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Discontinued |
No |
No |
AB |
2016/05/16
|
FLAMINGO PHARMS |
208162 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2016/05/25
|
ESJAY PHARMA |
206560 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2016/11/16
|
CADILA |
208681 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/06/20
|
ALEMBIC |
209096 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/09/12
|
LUPIN LTD |
209794 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
TABLET;ORAL |
250MG |
Prescription |
No |
No |
AB |
2017/12/12
|
CADILA PHARMS LTD |